Vitamin D and the central nervous system

Bartels, 2007, 1,25-Dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4+ T cells from patients with Crohn's disease, Int Immunopharmacol, 7, 1755, 10.1016/j.intimp.2007.09.016

Borowicz, 2007, Cholecalciferol enhances the anticonvulsant effect of conventional antiepileptic drugs in the mouse model of maximal electroshock, Eur J Pharmacol, 573, 111, 10.1016/j.ejphar.2007.07.002

Brewer, 2001, Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons, J Neurosci, 21, 98, 10.1523/JNEUROSCI.21-01-00098.2001

Brown, 2003, 1,25-Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons, Neurosci Lett, 343, 139, 10.1016/S0304-3940(03)00303-3

Buell, 2010, 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services, Neurology, 74, 18, 10.1212/WNL.0b013e3181beecb7

Chaudhuri, 2005, Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis, Med Hypotheses, 64, 608, 10.1016/j.mehy.2004.06.022

Correale, 2009, Immunomodulatory effects of vitamin D in multiple sclerosis, Brain, 132, 1146, 10.1093/brain/awp033

De Luca, 2004, Overview of general physiologic features and functions of vitamin D, Am J Clin Nutr, 80, 1689, 10.1093/ajcn/80.6.1689S

de Viragh, 1989, Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis, Proc Natl Acad Sci USA, 86, 3887, 10.1073/pnas.86.10.3887

Diesel, 2005, Vitamin D3 metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol, Clin Cancer Res, 11, 5370, 10.1158/1078-0432.CCR-04-1968

Dong, 2009, Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases, Acta Pharmacol Sin, 30, 379, 10.1038/aps.2009.24

Dursun, 2011, A novel perspective for Alzheimer's disease: Vitamin D receptor suppression by amyloid-β and preventing the amyloid-β induced alterations by vitamin D in cortical neurons, J Alzheimers Dis, 23, 207, 10.3233/JAD-2010-101377

Dusso, 2005, Vitamin D, Physiol Renal Physiol, 289, F8, 10.1152/ajprenal.00336.2004

Evatt, 2008, Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease, Arch Neurol, 65, 1348, 10.1001/archneur.65.10.1348

Eyles, 2011, Vitamin D in fetal brain development, Semin Cell Dev Biol, 22, 629, 10.1016/j.semcdb.2011.05.004

Eyles, 2013, Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease, Front Neuroendocrinol, 34, 47, 10.1016/j.yfrne.2012.07.001

Eyles, 2005, Distribution of the vitamin D receptor and 1α-hydroxylase in human brain, J Chem Neuroanat, 29, 21, 10.1016/j.jchemneu.2004.08.006

Falkenstein, 2000, Multiple actions of steroid hormones – a focus on rapid, nongenomic effects, Pharmacol Rev, 52, 513

Farid, 2012, Correlation between serum 25-hydroxyvitamin D concentrations and regional cerebral blood flow in degenerative dementia, Nucl Med Commun, 33, 1048, 10.1097/MNM.0b013e32835674c4

Fernandes de Abreu, 2009, Vitamin D, a neuro-immunomodulator: implications for neurodegen-erative and autoimmune diseases, Psychoneuroendocrinology, 34, 265, 10.1016/j.psyneuen.2009.05.023

Fernandes de Abreu, 2010, Developmental vitamin D deficiency alters learning in C57Bl/6J mice, Behav Brain Res, 208, 603, 10.1016/j.bbr.2010.01.005

Féron, 2005, Developmental vitamin D3 deficiency alters the adult rat brain, Brain Res Bull, 65, 141, 10.1016/j.brainresbull.2004.12.007

Ganji, 2010, Serum vitamin D concentrations are related to depression in young adult US population: the Third National Health and Nutrition Examination Survey, Int Arch Med, 11, 3

Garcion, 2002, New clues about vitamin D functions in the nervous system, Trends Endocrinol Metab, 13, 100, 10.1016/S1043-2760(01)00547-1

Gruszczynska-Biegala, 2011, Differential roles for STIM1 and STIM2 in store-operated calcium entry in rat neurons, PLoS One, 6, e19285, 10.1371/journal.pone.0019285

Handoko, 2006, Polymorphisms in the vitamin D receptor and their associations with risk of schizophrenia and selected anthropometric measures, Am J Hum Biol, 18, 415, 10.1002/ajhb.20504

Harms, 2011, Vitamin D and the brain, Best Pract Res Clin Endocrinol Metab, 25, 657, 10.1016/j.beem.2011.05.009

Harms, 2008, Developmental vitamin D deficiency alters adult behaviour in 129/SvJ and C57BL/6J mice, Behav Brain Res, 187, 343, 10.1016/j.bbr.2007.09.032

Holick, 2005, The vitamin D epidemic and its health consequences, J Nutr, 135, 2739S, 10.1093/jn/135.11.2739S

Holló, 2012, Correction of vitamin D deficiency improves seizure control in epilepsy: a pilot study, Epilepsy Behav, 24, 131, 10.1016/j.yebeh.2012.03.011

Hoogendijk, 2008, Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults, Arch Gen Psychiatry, 65, 508, 10.1001/archpsyc.65.5.508

Hua, 2012, Progesterone and low-dose vitamin D hormone treatment enhances sparing of memory following traumatic brain injury, Horm Behav, 61, 642, 10.1016/j.yhbeh.2012.02.017

Huang, 2012, Polymorphisms in the vitamin D receptor gene and multiple sclerosis risk: a meta-analysis of case-control studies, J Neurol Sci, 313, 79, 10.1016/j.jns.2011.09.024

Huh, 2008, Vitamin D deficiency in children and adolescents: epidemiology, impact and treatment, Rev Endocr Metab Disord, 9, 161, 10.1007/s11154-007-9072-y

Jamilian, 2013, Vitamin D, parathyroid hormone, serum calcium and phosphorus in patients with schizophrenia and major depression, Int J Psychiatry Clin Pract, 17, 30, 10.3109/13651501.2012.667111

Kalueff, 2006, Increased severity of chemically induced seizures in mice with partially deleted vitamin D receptor gene, Neurosci Lett, 394, 69, 10.1016/j.neulet.2005.10.007

Kesby, 2006, Developmental vitamin D deficiency alters MK 801-induced hyperlocomotion in the adult rat: an animal model of schizophrenia, Biol Psychiatry, 60, 591, 10.1016/j.biopsych.2006.02.033

Khanal, 2008, Membrane receptor-initiated signaling in 1,25(OH)2D3-stimulated calcium uptake in intestinal epithelial cells, J Cell Biochem, 105, 1109, 10.1002/jcb.21913

Kimball, 2007, Safety of vitamin D3 in adults with multiple sclerosis, Am J Clin Nutr, 86, 645, 10.1093/ajcn/86.3.645

Kiviluoto, 2011, STIM1 as a key regulator for Ca2+ homeostasis in skeletal-muscle development and function, Skelet Muscle, 4, 1

Lefebvre d’Hellencourt, 2003, : Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell line, J Neurosci Res, 71, 575, 10.1002/jnr.10491

Mackay-Sim, 2004, Schizophrenia, vitamin D, and brain development, Int Rev Neurobiol, 59, 351, 10.1016/S0074-7742(04)59014-1

May, 2010, Association of vitamin D levels with incident depression among a general cardiovascular population, Am Heart J, 159, 1037, 10.1016/j.ahj.2010.03.017

McGrath, 1999, Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia?, Schizophr Res, 40, 173, 10.1016/S0920-9964(99)00052-3

McGrath, 2003, Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera, Schizophr Res, 63, 73, 10.1016/S0920-9964(02)00435-8

McGrath, 2010, Neonatal vitamin D status and risk oof schizophrenia: a population-based case-control study, Arch Gen Psychiatry, 67, 889, 10.1001/archgenpsychiatry.2010.110

McGrath, 2004, Vitamin D, supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study, Schizophr Res, 67, 237, 10.1016/j.schres.2003.08.005

Mowry, 2011, Vitamin D, evidence for its role as a prognostic factor in multiple sclerosis, J Neurol Sci, 311, 19, 10.1016/j.jns.2011.06.035

Nemere, 2010, Intestinal cell calcium uptake and the targeted knockout of the 1,25D3-MARRS (membrane-associated, rapid response steroid-binding) receptor/PDIA3/Erp57, J Biol Chem, 285, 31859, 10.1074/jbc.M110.116954

Norman, 2008, From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health, Review. Am J Clin Nutr, 88, 491S, 10.1093/ajcn/88.2.491S

Pannu, 2006, Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms, Neurochem Int, 49, 170, 10.1016/j.neuint.2006.04.010

Puchacz, 1996, Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells, Brain Res Mol Brain Res, 36, 193, 10.1016/0169-328X(95)00314-I

Reichrath, 2010, Notch-and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines, J Steroid Biochem Mol Biol, 121, 420, 10.1016/j.jsbmb.2010.02.028

Robin, 2011, Nitric oxide scavenging modulates mitochondrial dysfunction induced by hypoxia/reoxygenation, Pharmacol Rep, 63, 1189, 10.1016/S1734-1140(11)70638-7

Rovner, 2008, among healthy children in the United States: a review of the current evidence, Arch Pediatr Adolesc Med, 162, 513, 10.1001/archpedi.162.6.513

Sanchez, 2009, 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum, J Neurosci Res, 87, 723, 10.1002/jnr.21878

Schuster, 2011, Cytochromes P450 are essential players in the vitamin D signaling system, Biochim Biophys Acta, 1814, 186, 10.1016/j.bbapap.2010.06.022

Shinpo, 2000, Effect of 1,25-dihydroxyvitamin D3 on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L-buthionine sulfoximine and 1-methyl-4-phenylpyridine, J Neurosci Res, 62, 374, 10.1002/1097-4547(20001101)62:3<374::AID-JNR7>3.0.CO;2-7

Smolders, 2008, Vitamin D as an immune modulator in multiple sclerosis, a review, J Neuroimmunol, 194, 7, 10.1016/j.jneuroim.2007.11.014

Sonnenberg, 1986, 1,25-Dihydroxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei, Endocrinology, 118, 1433, 10.1210/endo-118-4-1433

Tuohimaa, 2009, Vitamin D, nervous system and aging, Psychoneuroendocrinology, 34, 278, 10.1016/j.psyneuen.2009.07.003

Uitterlinden, 2004, Genetics and biology of vitamin D receptor polymorphisms, Gene, 338, 143, 10.1016/j.gene.2004.05.014

Valdivielso, 2006, Vitamin D, receptor polymorphisms and diseases, Clin Chim Acta, 371, 1, 10.1016/j.cca.2006.02.016

Van der Schueren, 2012, Straight from D-Heart: vitamin D status and cardiovascular disease, Curr Opin Lipidol, 23, 17, 10.1097/MOL.0b013e32834d7357

Vazquez, 1998, 1α,25-Dihydroxy-vitamin-D3-induced store-operated Ca2+ influx in skeletal muscle cells, Modulation by phospholipase C, protein kinase C, and tyrosine kinases. J Biol Chem, 273, 33954

Wang, 2005, Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes, Mol Endocrinol, 19, 2685, 10.1210/me.2005-0106

Waschbisch, 2012, Physical activity in multiple sclerosis: a comparative study of vitamin D, brain-derived neurotrophic factor and regulatory T cell populations, Eur Neurol, 68, 122, 10.1159/000337904

Webb, 2006, Who, what, where and when - influences on cutaneous vitamin D synthesis, Prog Biophys Mol Biol, 92, 17, 10.1016/j.pbiomolbio.2006.02.004

Yagishita, 2012, Vitamin D3 enhances all-trans retinoic acid (ATRA)-mediated neurosteroid biosynthesis in human glioma GI-1 cells, J Biochem, 152, 285, 10.1093/jb/mvs074

Zanatta, 2012, 1α,25-Dihydroxyvitamin D3 mechanism of action: Modulation of L-type calcium channels leading to calcium uptake and intermediate filament phosphorylation in cerebral cortex of young rats, Biochim Biophys Acta, 1823, 1708, 10.1016/j.bbamcr.2012.06.023